American Society of Hirudotherapy

Salivary transcriptome of the North American medicinal leech, Macrobdella decora

Basic science / transcriptomics published in J Parasitol (2010)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomics & ProteomicsSalivary PharmacologyMin GS et al. · The Journal of parasitology, 2010

Abstract

A variety of bioactive proteins from medicinal leeches, like species of Hirudo , have been characterized and evaluated for their potential therapeutic biomedical properties. However, there has not previously been a comprehensive attempt to fully characterize the salivary transcriptome of a medicinal leech that would allow a clearer understanding of the suite of polypeptides employed by these sanguivorous annelids and provide insights regarding their evolutionary origins. An Expressed Sequence Tag (EST) library-based analysis of the salivary transcriptome of the North American medicinal leech, Macrobdella decora, reveals a complex cocktail of anticoagulants and other bioactive secreted proteins not previously known to exist in a single leech. Transcripts were identified that correspond to each of saratin, bdellin, destabilase, hirudin, decorsin, endoglucoronidase, antistatin, and eglin, as well as to other previously uncharacterized predicted serine protease inhibitors, lectoxin-like c-type lectins, ficolin, disintegrins and histidine-rich proteins. This work provides a lens into the richness of bioactive polypeptides that are associated with sanguivory. In the context of a well-characterized molecular phylogeny of leeches, the results allow for preliminary evaluation of the relative evolutionary origins and historical conservation of leech salivary components. The goal of identifying evolutionarily significant residues associated with biomedically significant phenomena implies continued insights from a broader sampling of blood-feeding leech salivary transcriptomes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
Indexed MeSH termsAmino Acid SequenceAnimalsExpressed Sequence TagsGene Expression ProfilingHirudinsLeechesSalivaSalivary Proteins and Peptides

Summary

Expressed Sequence Tag library analysis of the salivary transcriptome of the North American medicinal leech Macrobdella decora. Identifies transcripts for saratin, bdellin, destabilase, hirudin, decorsin, endoglucoronidase, antistatin, eglin, plus uncharacterized serine protease inhibitors and lectoxin-like c-type lectins.

Why This Matters for Hirudotherapy

This study built an EST library to characterize, for the first time comprehensively, the salivary transcriptome of the North American medicinal leech Macrobdella decora, revealing a complex cocktail of bioactive secreted proteins — including transcripts for saratin, bdellin, destabilase, hirudin, decorsin, endoglucoronidase, antistatin, and eglin, plus previously uncharacterized serine-protease inhibitors, c-type lectins, ficolin, disintegrins, and histidine-rich proteins — and interpreting them against a leech molecular phylogeny. For hirudotherapy this directly enriches the medicinal-leech secretome drug-discovery narrative, showing that a single sanguivorous leech deploys a far broader anticoagulant/antiplatelet/anti-inflammatory toolkit than the familiar Hirudo molecules alone and pointing to Macrobdella as an additional source of candidate bioactives. The caveat is that this is a descriptive transcriptomic survey: it catalogs which proteins are expressed and their predicted families, but does not measure their activity, efficacy, or any clinical effect.

Citation

Salivary transcriptome of the North American medicinal leech, Macrobdella decora.

Min GS et al. · The Journal of parasitology, 2010

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.